CTLA-4 signaling plays a greater role in preventing the commencement of T-cell response; while PD-1 plays a more significant role later on and serves to abstract T-cell activity in the immunological setting of tumor microenvironment. This evidence concerns the gene CTLA4 and neoplasm.